pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Oncology · news · pharmadog
← back to Oncology
News · Oncology
1,499
stories
Apr 27, 26
Supreme Court grapples with multibillion-dollar wave of lawsuits over Roundup cancer claims
stat
Apr 27, 26
STAT+: Erasca touts strong, though preliminary, results in trial of pancreatic and lung cancer therapy
stat
Apr 27, 26
Erasca reports RAS cancer drug data after legal threat from Revolution
endpoints
Apr 27, 26
Revolution Medicines threatens to sue Erasca over patent, efficacy claims
endpoints
Apr 27, 26
Lilly to buy startup Ajax in bid for a better JAK drug
biopharma dive
Apr 27, 26
STAT+: Astellas retries XLMTM gene therapy after deaths
stat
Apr 27, 26
Lilly announces a new cancer deal, paying Ajax up to $2.3B for JAK inhibitor
endpoints
Apr 27, 26
Compass Therapeutics unveils key secondary endpoint results from pivotal biliary tract cancer trial
endpoints
Apr 25, 26
Nancy Cox, a CDC veteran and a stalwart in global flu research, dies at 77
stat
Apr 25, 26
Opinion: The podcast telling the stories behind Ambien, Ozempic, EpiPens, and other game-changing drugs
stat
Apr 24, 26
STAT+: A biotech VC on what Eli Lilly saw in a struggling cancer startup for $3.2B
stat
Apr 24, 26
STAT+: Utah medical board calls for immediate suspension of state’s AI doctor experiment
stat
Apr 24, 26
Sanofi MS drug rejected in US gets an endorsement in Europe
biopharma dive
Apr 24, 26
Novartis pulls Pluvicto prostate cancer label expansion filing in the EU
endpoints
Apr 24, 26
Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelics
biopharma dive
Apr 24, 26
International childhood vaccine campaign grows
stat
Apr 24, 26
Growing use of guest editors has turned some journals into a ‘playground of bad science’
stat
Apr 23, 26
A CAR-T biotech’s dramatic turnaround, and drugmakers’ tactics to drive more scripts
stat
Apr 23, 26
Heart’s beat may help it beat cancer, mouse research suggests
stat
Apr 23, 26
Drugmaker AbbVie chooses North Carolina for $1.4B manufacturing campus
biopharma dive
Apr 23, 26
Roche, facing biosimilar threats, puts faith in new cancer and obesity drugs
biopharma dive
Apr 23, 26
Sanofi posts upbeat sales as R&D pressure builds
biopharma dive
Apr 23, 26
Roche says its investigational breast cancer pill could outsell Herceptin
endpoints
Apr 22, 26
BridgeBio’s oncology spinoff swaps out CEOs as it seeks to accelerate KRAS work
endpoints
Apr 22, 26
Revolution drug shows promise in early pancreatic cancer
biopharma dive
Apr 22, 26
Merck adds to pharma’s AI push; Roche details MS drug results
biopharma dive
Apr 22, 26
An ‘AI scientist’ can tackle drug R&D. What does that mean for pharma?
biopharma dive
Dec 23, 25
Fierce Biotech Layoff Tracker 2026: Caribou cuts staff, halts pipeline; Foghorn reduces workforce by 40%
fiercebiotech
Dec 22, 25
Fierce Biotech Fundraising Tracker '26: Matchpoint makes $150M; KymaThera corrals $80M
fiercebiotech
← prev
page 50 of 50
next →
